Biotech Firms Acknowledge Minority Underrepresentation

Company officials cite an unfilled pipeline as an obstacle to recruitment; some observers see need for more aggressive recruiting. Sidebar: Helpful Resources For Minority Scientists TOO FEW: BIO president Carl Feldbaum cites the pipeline issue rather than discrimination as the main reason for small minority representation. Scientists who are members of racial and ethnic minorities are underrepresented in the biotechnology industry, according to a variety of industry observers. Minority resear

Written byRobert Finn
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Company officials cite an unfilled pipeline as an obstacle to recruitment; some observers see need for more aggressive recruiting.

Sidebar: Helpful Resources For Minority Scientists

While those in the industry say the problem is quite real, it is difficult to quantify. Large and small biotechnology companies approached by The Scientist declined to provide breakdowns on the racial and ethnic makeup of their scientific staffs. And the Washington, D.C.-based Biotechnology Industry Organization (BIO), the industry's main lobbying group, does not collect data on this issue, although BIO president Carl B. Feldbaum says he plans to do so in the future.

Despite this absence of data, Feldbaum is comfortable in charging that "there are too few minority scientists in the industry." But he's quick to add, "I haven't seen any whiff of explicit discrimination. I think [the problem is caused by] the small number of minorities in the general population who have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies